Patents-Review.com
ClassID:

21041 ⎘

A61K38/488 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on peptide bonds (3.4) Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E

Recent Application in this class:
#1
20260016491
2026-01-15

METHODS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS

 #2
20250268995
2025-08-28

COMPOSITIONS FOR BREAKDOWN OF GLUTEN PROTEINS

 #3
20250228896
2025-07-17

MATRIX BOUND NANOVESICLES ENCAPSULATED IN HYDROGELS

 #4
20250152678
2025-05-15

PROTEOLYTIC ENZYME COMPOSITION

 #5
20250064903
2025-02-27

COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE

 #6
20240382569
2024-11-21

FUNGAL ENZYME MIXTURES AND USES THEREOF

 #7
20240156922
2024-05-16

FUNGAL PROTEASE MIXTURES AND USES THEREOF

 #8
20240091170
2024-03-21

Catechol Nanoparticle, Catechol Protein Nanoparticle, and Preparation Method and Use Thereof

 #9
20240033332
2024-02-01

AGENT FOR ACTIVATING A NEURON

 #10
20230321205
2023-10-12

COMPOSITION COMPRISING TTF-NGR FOR USE IN TREATING SOFT-TISSUE SARCOMA

 #11
20230127775
2023-04-27

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS

 #12
20220088151
2022-03-24

Proteolytic enzyme composition

 #13
20220088130
2022-03-24

COMPOUNDS AND METHODS FOR TREATING LIVER DISEASES

 #14
20220065874
2022-03-03

METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES

 #15
20210270846
2021-09-02

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS

 #16
20210230569
2021-07-29

Treatment of gluten intolerance and related conditions

 #17
20210228694
2021-07-29

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS

 #18
20210220451
2021-07-22

Compositions and methods for treating gluten intolerance and disorders arising therefrom

 #19
20210169998
2021-06-10

Treatment of neuronal ceroid lipofuscinosis

 #20
20210093699
2021-04-01

Compositions and methods for treating gluten intolerance and disorders arising therefrom

 #21
20200385485
2020-12-10

PROLIFERATION OF MUC1 EXPRESSING CELLS

 #22
20200276360
2020-09-03

COMPOSITIONS AND METHODS FOR CARDIAC THERAPY

 #23
20200179481
2020-06-11

Flounder surimi having antioxidant and antihypertensive effects and method of preparing the same

 #24
20200129656
2020-04-30

ENZYMATIC WOUND DEBRIDING COMPOSITIONS WITH ENHANCED ENZYMATIC ACTIVITY

 #25
20200040322
2020-02-06

Treatment of gluten intolerance and related conditions

 #26
20190390203
2019-12-26

REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS

 #27
20190183985
2019-06-20

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS

 #28
20190060509
2019-02-28

Enzymatic wound debriding compositions with enhanced enzymatic activity

 #29
20190022194
2019-01-24

Compositions and methods for treating gluten intolerance and disorders arising therefrom

 #30
20180179545
2018-06-28

Reduction of lipase activity in product formulations

 #31
20180100139
2018-04-12

Decellularized human amniotic membrane for cell delivery, cell culture and inflammation prevention

 #32
20180071432
2018-03-15

Compositions and methods for cardiac therapy

 #33
20180038875
2018-02-08

METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES

 #34
20170348236
2017-12-07

METHOD FOR PRODUCING MICROPARTICLES

 #35
20170290894
2017-10-12

Compositions and methods for treating thyroid disease

 #36
20170232077
2017-08-17

Compositions and methods for treating gluten intolerance and disorders arising therefrom

 #37
20170119861
2017-05-04

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS

 #38
20170072029
2017-03-16

Enzymatic wound debriding compositions with enhanced enzymatic activity

 #39
20170067040
2017-03-09

Treatment of gluten intolerance and related conditions

 #40
20160346364
2016-12-01

Medicament and method for treating innate immune response diseases

 #41
20160312226
2016-10-27

Reduction of lipase activity in product formulations

 #42
20160302446
2016-10-20

Use of aspergilloglutamic peptidase to improve animal performance

 #43
20160271205
2016-09-22

Use of angiotensin II (AII) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps

 #44
20160206562
2016-07-21

METHOD FOR PRODUCING MICROPARTICLES

 #45
20160199461
2016-07-14

Treatment of synucleinopathies

 #46
20160022785
2016-01-28

COMPOSITIONS AND METHODS FOR TREATING GLUTEN INTOLERANCE AND DISORDERS ARISING THEREFROM

 #47
20150297687
2015-10-22

PROTEASE COMPOSITIONS FOR THE TREATMENT OF DAMAGED TISSUE

 #48
20150290301
2015-10-15

TREATMENT OF GLUTEN INTOLERANCE AND RELATED CONDITIONS

 #49
20150265686
2015-09-24

Treatment of gluten intolerance and related conditions

 #50
20150218288
2015-08-06

Method for stimulating or enhancing proliferation of cells by activating the mucin 1 (MUC1) receptor

 #51
20150197738
2015-07-16

Acid Stable Prolyl Endopeptidases for Degrading Gluten

 #52
20150125538
2015-05-07

Compositions and methods for oxalate reduction

 #53
20150086565
2015-03-26

Cancer-related extracellular matrix signatures and related methods and products

 #54
20150017151
2015-01-15

Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

 #55
20140369996
2014-12-18

Chymosin for the Prevention and Treatment of Gastrointestinal Disorders

 #56
20140271609
2014-09-18

Methods of treatment of cellulite

 #57
20140248258
2014-09-04

METHODS FOR IMPROVING GUT HEALTH

 #58
20140186330
2014-07-03

Treatment of gluten intolerance and related conditions

 #59
20140140980
2014-05-22

Treatment of gluten intolerance and related conditions

 #60
20140044694
2014-02-13

Pharmaceutical composition for treating lysosomal storage disease

 #61
20140010788
2014-01-09

Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy

 #62
20130177549
2013-07-11

Treatment of synucleinopathies

 #63
20130156884
2013-06-20

PROTEASE ENZYMES FOR INCREASED PROTEIN DIGESTION RATE AND ABSORPTION AND METHODS OF USING THE SAME

 #64
20130085461
2013-04-04

Method for Pre-Debriding Treatment of Non-Viable Skin Tissue and Compositions and System Thereof

 #65
20130045196
2013-02-21

Enzymatic wound debriding compositions with enhanced enzymatic activity

 #66
20120276075
2012-11-01

SYNERGIC ACTION OF A PROLYL PROTEASE AND TRIPEPTIDYL PROTEASES

 #67
20120264190
2012-10-18

Decellularized and Delipidized Extracellular Matrix and Methods of Use

 #68
20120225050
2012-09-06

Methods for improving gut health

 #69
20120156250
2012-06-21

Compositions and methods for cardiac therapy

 #70
20120020947
2012-01-26

COMPOSITIONS AND METHODS FOR INCREASING LEAN MUSCLE MASS AFTER EXERCISE

 #71
20110182818
2011-07-28

Methods and compositions for the treatment of symptoms of neurological and mental health disorders

 #72
20110104286
2011-05-05

PHARMACEUTICAL COMPOSITIONS CONTAINING THE ENZYME CYPROSIN, AN ASPARTIC PEPTIDASE FROM CYNARA CARDUNCULUS AND ITS INCLUSION IN ANTITUMOUR FORMULATIONS

 #73
20110064721
2011-03-17

CATHEPSIN-D NEUROPROTECTION

 #74
20110038851
2011-02-17

Treatment of synucleinopathies

 #75
20100322912
2010-12-23

Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Celiac Sprue Patients

 #76
20100203034
2010-08-12

Methods for the treatment and prevention of diseases of biological conduits

 #77
20100160232
2010-06-24

Physiologically active complex comprising protamine and/or salt therefor and an acidic macromolecular substance, and use thereof

 #78
20100104547
2010-04-29

TOPICAL COMPOSITION FOR THE TREATMENT OF ALLERGENIC EFFECTS

 #79
20100047227
2010-02-25

NOVEL ANTICANCER CATHEPSIN FORMULATIONS AND ANTICANCER AGENT FOR USE IN COMBINED ANTICANCER THERAPY

 #80
20100003237
2010-01-07

Methods of treatment of collagen-mediated diseases and conditions

 #81
20090285776
2009-11-19

Irreversibly-inactivated pepsinogen fragments for modulating immune function

 #82
20090214554
2009-08-27

TRUNCATED MEMAPSIN 2 COMPOSITIONS AND TREATMENTS

 #83
20090208474
2009-08-20

BIOLOGICAL ENTITIES AND THE USE THEREOF

 #84
20090208440
2009-08-20

BIOLOGICAL ENTITIES AND THE USE THEREOF

 #85
20090136478
2009-05-28

Methods for using enzymes to disintegrate cancerous tumors in vivo

 #86
20090117092
2009-05-07

Collagenolytic active enzyme containing compositions, and their use in the dental field

 #87
20090010913
2009-01-08

Natural liniment for treatment of skin cancers

 #88
20080241122
2008-10-02

Dental Composition Comprising Enzyme

 #89
20080213196
2008-09-04

Enzyme containing composition, process of producing said composition and its use

 #90
20080175848
2008-07-24

Methods for treating conditions associated with the accumulation of excess extracellular matrix

 #91
20080131487
2008-06-05

CHYMOSIN FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS

 #92
20080044459
2008-02-21

Enzymatic debridement therapy for abnormal cell proliferation

 #93
20070218121
2007-09-20

Compounds that inhibit caspase activity for treating glaucoma

 #94
20070212343
2007-09-13

COMPOSITIONS FOR TREATMENT OF EAR INFECTIONS

 #95
20070212342
2007-09-13

Protease compositions for the treatment of damaged tissue

 #96
20070184118
2007-08-09

Compositions and methods for oxalate reduction

 #97
20070141042
2007-06-21

Methods for the treatment and prevention of diseases of biological conduits

 #98
20070110739
2007-05-17

Wipe away pain

 #99
20070092517
2007-04-26

TRUNCATED MEMAPSIN 2 COMPOSITIONS AND TREATMENTS

 #100
20070065456
2007-03-22

Nutritional supplements

 #101
20070003486
2007-01-04

Ointment wound spray

 #102
20060222637
2006-10-05

Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors

 #103
20060115436
2006-06-01

Enzyme containing composition, process of producing said composition and its use

 #104
20060034848
2006-02-16

Methods and compositions for treating Alzheimer's disease

 #105
20050265932
2005-12-01

Collagenolytic active enzyme containing compositions, and their use in the dental field

 #106
20050175581
2005-08-11

Biological entities and the pharmaceutical and diagnostic use thereof

 #107
20050152887
2005-07-14

Protonic formulation

 #108
20050124534
2005-06-09

Methods for treating conditions associated with the accumulation of excess extracellular matrix

 #109
20050065184
2005-03-24

Method of reducing the risk of oxidative stress

 #110
20050059126
2005-03-17

Engineered enzymes and uses thereof

 #111
20050036950
2005-02-17

Ointment wound spray

 #112
20050002897
2005-01-06

Biological entities and the pharmaceutical or diagnostic use thereof

 #113
14298414
2017-04-25

Control of acid reflux with botanicals